Find Academic Supervisors

Wen JiangView profile

Professor

• Cryo-EM Structural Biology
• Biophysics Computing
• In situ Structural Biology
• +4 more

Wen Jiang is the Dorothy Foehr Huck and J. Lloyd Huck Chair in Structural Biology and Professor of Biochemistry & Molecular Biology at Penn State University. He leads the Jiang Lab, specializing in cryo-EM structural biology, biophysics computing, and in situ structural techniques like CLEM and electron tomography. His research focuses on amyloids, viruses, and protein complexes, alongside methodological advancements in cryo-EM sample preparation and data analysis. Education: B.S. in Physics (Peking University), M.S. in Biophysics (Chinese Academy of Sciences), Ph.D. and postdoc in Cryo-EM (Baylor College of Medicine under Prof. Wah Chiu). Research interests include structural studies of neurodegenerative disease-related amyloids, viral structures, and the development of computational tools for cryo-EM (e.g., Helicon, CryoVR). The lab collaborates across disciplines, welcoming candidates in biology, physics, engineering, and computer science. Prominent software contributions include MotionCorr enhancements, jspr for image processing, and web apps like map2seq and ProCart. Alumni have transitioned to roles at institutions like NIH, HHMI Janelia, and industry positions in biotechnology. Key lab activities include cryo-EM methodology, viral vaccine design using pseudoviruses, and structural studies of bacterial enzymes and viral capsids. Collaborations focus on applying cryo-EM to biomedical challenges like neurodegeneration and infectious diseases.

• Soft Matter Physics
• Colloid Science
• Microgel Technology
• +3 more

Prof. Jérôme Crassous is a Junior Professor at RWTH Aachen University's Department of Physical Chemistry of Soft Matter. His research focuses on microgel systems, soft matter physics, and responsive materials. Key interests include colloidal self-assembly, anisotropic particle design, and applications in biomaterials and tissue engineering. His work bridges experimental, theoretical, and computational approaches to study microgel behavior under varying conditions, such as temperature, electric fields, and magnetic actuation. Recent studies highlight programmable microgel actuators, interfacial assembly at air-water interfaces, and biocompatible encapsulation techniques. Publications emphasize structural control of microgels (e.g., core-shell, hollow, rod-shaped geometries), phase transitions, and interactions with lipid membranes. Applications span drug delivery, smart materials, and fluid dynamics control. No scientific awards are explicitly listed in the provided texts. His research group explores advanced fabrication methods like microfluidics and cryo-TEM for material characterization.

• Circadian Rhythms
• Antiviral Immunity
• Osmotic Homeostasis
• +5 more

Dr. Rachel Edgar is a Senior Research Fellow in the Department of Infectious Disease at Imperial College London's Faculty of Medicine. Her research focuses on how cellular homeostasis and circadian rhythms influence viral infection outcomes. She leads a team investigating osmotic balance, protein homeostasis, and biomolecular condensates in antiviral immunity, with particular attention to respiratory pathogens like SARS-CoV-2 and influenza. Key affiliations include the Immuno-Pathology Network and Section of Virology. Education: PhD in herpesvirus biology from the University of Cambridge (2012) Postdoctoral work at the University of Cambridge Institute of Metabolic Science and MRC Laboratory of Molecular Biology Research Interests: Dr. Edgar's lab explores how circadian clocks, cellular stress responses, and environmental factors modulate infection susceptibility. Her work reveals time-of-day-dependent viral replication rates and identifies mechanisms where cellular clocks are hijacked by viruses. Recent studies highlight propylene glycol's efficacy in inactivating airborne viruses and the role of CRYPTOCHROME proteins in protein homeostasis. Scientific Achievements: Holder of the Royal Society - Wellcome Sir Henry Dale Fellowship. Her group's discoveries on circadian rhythms' impact on antiviral defenses have advanced understanding of infection dynamics. Collaborations include developing novel infection prevention strategies targeting cellular timekeeping mechanisms. Supervised students: Dr Christine Styles, Dr Aiwei Zeng Labs/Teams: Focus on primary cell models and natural host-pathogen systems Grants & Future Work: Ongoing projects investigate circadian-based interventions to reduce viral transmission and explore osmotic stress pathways in antiviral immunity. Her lab aims to translate fundamental discoveries into clinical applications against emerging pathogens.

David A. WeitzView profile

Professor

• Soft Condensed Matter
• Biophysics
• Microfluidics
• +4 more

David A. Weitz is the Mallinckrodt Professor of Physics and Applied Physics at Harvard University, holding joint appointments in the Department of Systems Biology and directing the Harvard Materials Research Science & Engineering Center. He also co-directs the Harvard Kavli Institute for Bionano Science & Technology and the BASF Advanced Research Initiative. His research focuses on soft condensed matter, biophysics, and microfluidics, with applications in materials science, drug delivery, and high-throughput screening. Weitz earned his B.Sc. from the University of Waterloo (1973), and A.M. and Ph.D. in Physics from Harvard (1975, 1978). After roles at Exxon Research and the University of Pennsylvania, he joined Harvard in 1999. Affiliations: Harvard University (Primary), TUM-IAS (Former Hans Fischer Senior Fellow, 2008). Key Appointments: Director of Harvard Materials Research Science & Engineering Center, Co-director of Harvard Kavli Institute. Research interests span colloidal systems, biomaterial mechanics, and microfluidic engineering for encapsulation and diagnostics. His lab pioneered microfluidic droplet techniques for creating designer emulsions and high-throughput assays. Current projects include biocompatible nanocapsule design, CO₂ mineralization, and studying biomolecular condensates in cells. Publications highlight advances in colloidal glasses, liquid crystal defects, and droplet deformation physics. Awards include Fellowships from the American Physical Society, Optical Society, and Biophysical Society, alongside prestigious lectureships (e.g., Jean Perrin Lecture). Grant activities include collaborations with industry and initiatives like The Salata Institute for Climate and Sustainability. His lab supports interdisciplinary training, with recent milestones including PhD defenses and microfluidics-based sustainability projects.

• Protein Crystallization
• Structural Biology
• Microfluidics
• +4 more

Dominique Maes is a Professor in the Department of Structural Biology within the Department of Bio-engineering Sciences at Vrije Universiteit Brussel. With an academic career spanning from 1987 to present, Maes has established significant expertise in protein crystallization, structural biology, and microfluidics. Their research focuses on fundamental mechanisms of protein crystallization, nucleation phenomena, and more recently, phase separation processes related to neurodegenerative diseases. Maes' research interests center on the physical principles governing protein behavior, particularly in crystallization and phase separation processes. Their work bridges fundamental biophysics with practical applications in biomanufacturing and disease mechanisms. The research utilizes advanced microfluidic platforms for precise control of protein solutions, enabling detailed studies of crystallization pathways, aggregation behavior, and phase separation dynamics under controlled conditions. Analysis of Maes' publication record reveals a clear evolution from fundamental crystallization studies toward applications in neurodegenerative disease research. Recent publications (2023-2025) show a strong focus on ALS-related protein phase separation, protein aggregation in microfluidic environments, and advanced particle tracking methods for microfluidic systems. The research demonstrates increasing interdisciplinary integration between structural biology, microfluidics, and neuroscience. IMT Microfluidics on Glass Poster Award (2019) Poster Prize (2018) European Space Agency Team Achievement Award (2007) Maes actively supervises doctoral research and serves on multiple PhD committees, particularly in the Department of Bio-engineering Sciences. They lead several major research projects including PROCRYSTAL (Crystallisation towards efficient and sustainable biomanufacturing), SRP97 (Microfluidic cell handling for subcellular dynamics), and FWOTM1122 (Characterizing mutations in hnRNPA2 for degenerative disorders). Their laboratory appears to focus on structural biology with strong connections to microfluidics research groups. Maes has established significant collaborations with researchers across Europe, particularly in microfluidics and protein science. The research group maintains active partnerships with multiple institutions for joint PhD programs and collaborative projects in structural biology and biomanufacturing applications.

Brandon RuotoloView profile

Professor

• Chemical Biology
• Biomacromolecular Chemistry
• Analytical Chemistry
• +2 more

Brandon Ruotolo is a Professor of Chemistry and Associate Chair for Research at the University of Michigan Department of Chemistry. His research focuses on developing ion mobility-mass spectrometry (IM-MS) for structural biology, particularly analyzing protein complexes and their interactions. He holds a PhD from Texas A&M University and completed postdoctoral work at the University of Cambridge. Key research areas include biomacromolecular chemistry, analytical chemistry, and pharmaceutical applications of structural mass spectrometry. His group explores gas-phase protein unfolding (CIU), protein self-assembly, and integrative structural biology. Notable awards include the 2023 Biemann Medal and 2024 Ken Standing Award. Recent work emphasizes IM-MS integration with other techniques, advancing drug discovery and biotherapeutic characterization. The lab actively mentors students (e.g., Iliana Levesque, Carolina Rojas Ramirez), and collaborates on projects like membrane protein analysis and amyloid formation mechanisms. Lab resources include advanced mass spectrometry instrumentation and computational tools. Active grants include NSF support for creativity and Agilent Thought Leadership funding. The group's mission is to bridge analytical and structural chemistry for biomedical applications.

Helen MirandaView profile

Assistant Professor

• Motor neuron diseases
• Stem cell biology
• Neurodegenerative disorders
• +7 more

Helen Miranda is an Assistant Professor in the Departments of Genetics and Genome Sciences and Neurology at Case Western Reserve University School of Medicine. Her research focuses on modeling motor neuron diseases (MNDs) using induced pluripotent stem cells (iPSCs), with a focus on spinal bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS). She develops co-culture systems to study interactions between motor neurons, astrocytes, and skeletal muscles. Dr. Miranda holds a PhD in Cell and Molecular Biology from the University of São Paulo and completed postdoctoral training at UC San Diego, where she pioneered iPSC models for neurodegenerative disorders. Her work bridges basic science and translational medicine, aiming to identify novel therapeutic targets. Education: BS in Biomedicine (State University of Londrina), MS in Immunopathology (State University of Londrina), PhD in Cell and Molecular Biology (University of São Paulo). Postdoctoral Fellowships: La Spada and Muotri Labs, UC San Diego. Research Interests: iPSC modeling of neuromuscular disorders, cell-autonomous/non-autonomous pathophysiology, drug discovery for neurodegeneration, co-culture systems for disease mechanisms, and translational neuroscience. Publications: Over 26 peer-reviewed articles in journals like Cell Reports, Neuron, and Stem Cells Dev. Recent work focuses on TFEB signaling in neuroinflammation, mitochondrial stress in ALS, and optogenetic neuromuscular junction models. Labs/Teams: Leads a lab at Case Western Reserve University focused on iPSC-based disease modeling and therapeutic screening for motor neuron diseases.

• Protein therapeutics formulation
• Biopharmaceutical delivery systems
• Protein-material interactions
• +3 more

Reza Nejadnik is an Associate Professor in the Department of Pharmaceutical Sciences and Experimental Therapeutics at the University of Iowa College of Pharmacy. His research focuses on protein pharmaceuticals, formulation optimization, and biophysical characterization of therapeutic proteins. He holds a PhD in Materials Science and Engineering from the University of Groningen, Netherlands, with postdoctoral experience at institutions including The University of Texas, Northwestern University, and Radboud University Nijmegen. Prior to academia, he led formulation development at Sanofi's Global Biologic Drug Product team in Frankfurt, Germany. His work addresses challenges in protein aggregation, surfactant removal, and stability during manufacturing and delivery processes. Education: PhD: Materials Science and Engineering, University of Groningen (2009) MSc: Biomedical Engineering (Biomaterials), Amirkabir University of Technology BSc: Materials Science and Engineering, Isfahan University of Technology Research Interests: Formulation and delivery of monoclonal antibodies and novel biologics Protein-surface interactions and adsorption mechanisms Stability of protein therapeutics under handling/administration conditions Development of closed-system drug delivery devices Recent Research Trends: Recent studies emphasize formulation challenges in surfactant removal, antibody stability under compounding conditions, and aggregate formation during infusion. His work bridges fundamental biophysical insights with translational drug product development. Labs/Teams: Directs the Nejadnik Laboratory, focusing on advancing protein pharmaceutical formulation and delivery technologies. Collaborates widely with industry partners and academic researchers in Europe and North America.

Maria Cristina GambettaView profile

Associate Professor

• Genomics
• Epigenetics
• Gene Regulation
• +7 more

Maria Cristina Gambetta is an Associate Professor at the Center for Integrative Genomics (CIG), within the Faculty of Biology and Medicine at the University of Lausanne (UNIL), Switzerland. She leads a research group focused on the molecular mechanisms of gene regulation, particularly in the context of chromatin architecture and genome organization in Drosophila melanogaster . Born in the United States, with Italian and Ecuadorian nationality Master's degree in Biology, University of Geneva (2006) Joint PhD from EMBL Heidelberg and University of Geneva (2010), under Prof. Jürg Müller and Dr. Daniel Pauli Postdoctoral training at Max Planck Institute of Biochemistry (2010–2014) and EMBL Heidelberg (2015–2017) Appointed Assistant Professor at UNIL-CIG (2018), promoted to Associate Professor (2023) Her research centers on understanding how gene regulators locate and interact with target genes across vast genomic distances. She investigates the function of insulator proteins in organizing 3D genome architecture and how these structures regulate gene expression. Her group has uncovered unique chromatin folding patterns in neurons and explores whether dynamic spatial proximity between regulatory elements and genes serves as a transcriptional control mechanism. Her work bridges biochemistry, genomics, and molecular genetics to dissect epigenetic regulation. The most recent publications highlight her group’s focus on insulator proteins (e.g., Cp190, CTCF), enhancer-blocking mechanisms, and the role of 3D genome organization in neuronal gene regulation. These studies employ techniques such as insulator-seq, chromatin conformation capture, and Drosophila genetics to reveal principles of long-range gene control. Her work spans evolutionary genomics, developmental biology, and structural insights into chromatin regulators. Scientific Awards: None explicitly mentioned in the provided text. Advising and Grants: Maria Cristina Gambetta has supervised several master’s and doctoral students and continues to mentor early-career researchers. Her research is supported by competitive grants, though specific funding sources are not detailed. She actively recruits PhD and postdoctoral candidates, indicating sustained research activity and funding. Labs and Teams: She leads the Gambetta Lab at the Center for Integrative Genomics, UNIL, which is part of a vibrant research environment that includes core facilities for genomics and protein analysis. Her team collaborates with leading groups in epigenetics and developmental biology, including former mentors such as Prof. Jürg Müller and Prof. Eileen Furlong.

Gabsang LeeView profile

Professor

• Cellular and Molecular Neuroscience
• Neurobiology of Disease
• Stem Cell Biology
• +11 more

Gabsang Lee is a Professor in the Department of Neurology and Neuroscience at the Johns Hopkins University School of Medicine. He leads a research laboratory focused on human pluripotent stem cells (hiPSCs) and reprogramming technologies to study cell fate specification in the context of neural and skeletal muscle diseases. His research interests include: Cellular and molecular mechanisms of neural crest development Disease modeling of peripheral neuropathies and neurodevelopmental disorders Skeletal muscle differentiation and muscular dystrophies hiPSC-based drug discovery and regenerative medicine Direct reprogramming of somatic cells into neural crest lineages The most recent publications reflect a strong trend in using advanced stem cell models to understand neurodegenerative diseases such as Parkinson’s and ALS, as well as muscular dystrophies. His work integrates multi-omics, optogenetics, and high-throughput screening to uncover disease mechanisms and identify therapeutic candidates. A significant portion of his research focuses on patient-specific modeling, enabling precision medicine approaches. Dr. Lee has received research funding from a wide array of sources, including: National Institutes of Health (NIH) National Science Foundation (NSF) Muscular Dystrophy Association (MDA) The CMT Association The FSH Society The New York Stem Cell Foundation The Scleroderma Research Foundation Johns Hopkins School of Medicine Private and industry partners including Vita Therapeutics and Stealth Biotherapeutics He actively mentors a diverse team of postdoctoral fellows, graduate students, and undergraduate researchers. Several former lab members have advanced to faculty or research scientist positions, indicating successful mentorship and training. His lab also collaborates broadly across institutions and disciplines. Dr. Lee’s lab is part of the Institute for Cell Engineering at Johns Hopkins, where they develop and apply cutting-edge stem cell technologies to model human diseases and test therapeutic interventions.

• Neuroscience
• Neurology
• Neurodegeneration
• +6 more

Stephen M. Strittmatter, the Vincent Coates Professor of Neurology and Neuroscience at Yale School of Medicine, serves as Chair of the Department of Neuroscience and Director of the Kavli Institute for Neuroscience. His research focuses on molecular mechanisms limiting axonal growth and neurodegeneration in Alzheimer's disease and spinal cord injury, translating discoveries to clinical trials. A Harvard College AB (1980) and Johns Hopkins MD/PhD (1986) graduate, he completed neurology residency at Massachusetts General Hospital before joining Yale in 1993. Alzheimer's disease Spinal cord injury Progranulin/TMEM106B interactions Prion protein signaling Synaptic loss mechanisms CRISPR-based neuroregeneration Recent publications highlight advancements in synaptic density imaging (via [18F]SynVesT-1 and SV2A), genetic risk factors (X-chromosome-wide association studies), and neuroregenerative therapies using Nogo receptor decoys. His work bridges molecular discovery with clinical application, particularly in the Strittmatter Laboratory at Yale. Scientific Honors : King Faisal International Prize for Medicine (2021) NINDS Outstanding Investigator R35 Award (2016) Alzheimer's Association Zenith Fellows Award (2013) Senator Jacob Javits Neuroscience Award (2005) Elected Member, Association of American Physicians (2024) Clinically, Dr. Strittmatter directs the Memory Disorders Clinic, specializing in Alzheimer's and related dementias. His research team collaborates with institutions like the Kavli Institute for Neuroscience and WHRY (Women's Health Research at Yale), with funding from NIH, Ameritec Foundation, and the Donaghue Foundation.

David BrockwellView profile

Professor

• Protein Folding and Stability
• Biophysics
• Mechanical Force in Biology
• +7 more

David Brockwell is a Professor of Biochemistry and Molecular Biology at the University of Leeds, Faculty of Biological Sciences, School of Molecular and Cellular Biology. He is based at the Astbury Centre for Structural Molecular Biology and leads research in protein folding, mechanical stability, biopharmaceutical aggregation, and protein hydrogel engineering. Current Position: Professor (2020–present) Previous Academic Roles: Associate Professor (2012–2020), URF/Lecturer (2004–2012) Education: BSc and PhD from the University of Manchester Postdoctoral Experience: University of Manchester (1997–1998), University of Leeds (1998–2004) His research explores the fundamental biophysics of proteins under mechanical and hydrodynamic stress, with applications in drug development and biomaterials. He investigates how force and flow affect protein stability, aggregation in biopharmaceuticals, outer membrane protein folding, and the design of functional protein hydrogels. The recent publications reflect a strong trend in applying single-molecule techniques like atomic force microscopy to understand protein mechanics, combined with in vivo and in vitro systems to address industrial and biomedical challenges. Key themes include manufacturability of biologics, mechanical strength of bacterial adhesion proteins, and engineering of functional biomaterials. He has received no explicitly mentioned scientific awards in the provided text. David Brockwell supervises postgraduate researchers and leads the Biochemistry undergraduate programme. His group collaborates extensively with experts in mechanical engineering, physics, and structural biology. He has secured research funding for projects such as EMBeDs (Ensuring Manufacturability of next-generation Biopharmaceuticals by Design) and hydrogel development. His lab is actively involved in developing new technologies for studying biomolecular interactions and advancing protein-based therapeutics and materials.

Wendy OlivasView profile

Associate Professor

• Molecular Biology
• RNA Biology
• Puf/Pumilio Proteins
• +2 more

Wendy Olivas is an Associate Professor in the Department of Biology at the University of Missouri-St. Louis. Her research focuses on the molecular mechanisms of Puf/Pumilio RNA-binding proteins in regulating mRNA lifespans and protein production, utilizing yeast ( Saccharomyces cerevisiae ) and human neural cell models. Education: PhD in Biochemistry and Molecular Biology from University of Nebraska Medical Center (1996) BS in Chemistry from Nebraska Wesleyan University (1992) Her laboratory investigates how Puf proteins mediate mRNA degradation and respond to environmental and cellular signals. This work bridges fundamental molecular biology with RNA regulatory networks in eukaryotic systems. Publications highlight her expertise in RNA biology, stress response mechanisms, and cross-species comparisons in microbial ecology. Notably, she has contributed to understanding Parkinson’s disease gene regulation via Pumilio proteins and microRNAs in neuronal cells, and microbial community dynamics in deadwood ecosystems. Dr. Olivas serves as a member of academic communities through peer-reviewed journal contributions and collaborative research activities.

Austen MilnerwoodView profile

Professor

• Neurodegenerative Disorders
• Parkinson's Disease
• Synaptic Plasticity
• +5 more

Dr. Austen Milnerwood is a Professor at McGill University's Faculty of Medicine and a principal investigator at The Neuro (Montreal Neurological Institute-Hospital), where he leads the Neurodegenerative Disorders Research Group. He was awarded the prestigious Killam Laureate fellowship (2017-2022) and has received Bell - Brain Canada Bipolar Research funding. His research program focuses on understanding the early pathophysiology of neurodegenerative diseases, particularly Parkinson's and Alzheimer's, as well as bipolar disorder. Dr. Milnerwood's research employs cell biological, electrophysiological, and optical approaches to investigate neural development, connectivity, transmission, and plasticity. His lab has made significant contributions to understanding Parkinson's disease mechanisms, particularly regarding proteins like LRRK2, VPS35, and synuclein, demonstrating their roles in synaptic function and immune signaling interactions. His innovative work on personalized medicine for bipolar disorder uses patient-derived stem cells to create neuronal models that help identify biological bases for differential treatment responses, particularly to lithium. His publication record shows consistent productivity with multiple high-impact publications in 2024-2025, demonstrating ongoing research momentum. His work reveals how LRRK2 inhibition can rapidly reverse dopamine dysfunction in Parkinson's models and identifies cellular pathways explaining differential responses to bipolar disorder treatments. His research bridges basic neuroscience with clinical applications, focusing on early disease mechanisms that could be targeted for prevention or intervention. Killam Laureate (2017-2022) Bell - Brain Canada Bipolar Research award Dr. Milnerwood leads an active research team utilizing advanced techniques including electrophysiology, optical recording, stem cell-derived neuronal models, and in vivo recording in rodent models. He has secured significant funding, including CIHR grants as noted in February 2025. His research is highly collaborative, working with Professor Guy Rouleau at McGill and Professor Martin Alda at Dalhousie University on bipolar disorder research, and with numerous other experts in Parkinson's disease and neurodegeneration. The Milnerwood Lab maintains specialized facilities for studying neural function, with equipment for electrophysiology, cell culture, and imaging. His lab's work on Parkinson's disease has identified that LRRK2 silencing could be therapeutically useful, as demonstrated by resistance to synuclein aggregation in LRRK2 knock-out mice and reversal of dopamine dysfunction through LRRK2 inhibition. His bipolar disorder research has developed human neuron circuit models that detect differences in electrical activity between patient and control neural networks.

Ina HuppertzView profile

Academic

• RNA Biology
• Post-transcriptional Gene Regulation
• RNA-Binding Proteins
• +7 more

Dr. Ina Huppertz is the Max Planck Research Group Leader at the Max Planck Institute for Biology of Ageing in Cologne, Germany. She leads an independent research group focused on RNA-binding proteins and their roles in metabolic regulation, stem cell differentiation, and gene expression. Her work bridges molecular biology, RNA biochemistry, and systems biology. Education: PhD in Molecular Biology, University of Cambridge (2012–2015) BSc in Life Sciences, Jacobs University Bremen (2009–2012) Her research interests center on RNA-binding proteins , riboregulation , and post-transcriptional control of metabolism . She investigates how RNA-protein interactions regulate key metabolic enzymes and influence cell fate decisions, particularly in embryonic stem cells. Her lab employs cutting-edge techniques such as iCLIP to map protein-RNA interactions at nucleotide resolution. The recent publications demonstrate a strong trend in understanding how RNA-binding proteins regulate metabolic pathways, stem cell differentiation, and autophagy. Her work combines mechanistic biochemistry with systems-level analysis, contributing to fields such as RNA biology, cellular metabolism, and neurodegeneration. Scientific Awards: Marie Skłodowska-Curie Individual Fellowship (2017–2019) Marie Curie ITN Fellowship (RNPnet) Benefactors’ Scholarship, St. John’s College Amgen Scholars Program Scholarship (2011) German National Academic Foundation Scholarship (2010–2012) Dr. Huppertz has secured competitive third-party funding, including a DFG Research Grant (2022–2024) on metabolic control in stem cells and an EMBL Technology Development Fund award (2021). She actively mentors a team of PhD students and postdoctoral researchers, including Lea Hund, Chrysi Kapsali, Lea Josefin Kaufmann, Ellie Koletsou, Julia Meier, and Tuğçe Soylu. Her lab also hosts guest scientists and student assistants. She leads the Max Planck Research Group Huppertz, which includes a multidisciplinary team of scientists, technicians, and students focusing on RNA biology and metabolism. The group fosters collaborative and innovative research in a dynamic environment at one of Europe’s leading institutes for molecular aging research.